KFSHRC's Dr. Jackie Ying named in Forbes 50 Over 50 Global 2025 list
Dr. Ying is widely regarded as a pioneering scientist in nanoscience, biomedical engineering, and translational medicine. With over 400 research papers and 200 patents, her work has transformed precision medicine, drug delivery, regenerative medicine, and diagnostic technologies, shaping the future of global healthcare.
At KFSHRC, Dr. Ying is leading novel advancements in AI-powered diagnostics, personalized medicine, and translational research. Her visionary leadership pushes KFSHRC's global leadership in research further. Beyond her scientific breakthroughs, Dr. Ying serves as a role model for women in STEM, advocating for inclusivity and scientific empowerment.
The Forbes 50 Over 50 Global 2025 list celebrates individuals whose impact transcends borders. Dr. Ying's pioneering efforts place her among the world's most influential scientific leaders, reinforcing KFSHRC's dedication to fostering global research talent and driving healthcare innovation.
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
5 days ago
- Zawya
Merck Foundation Chief Executive Officer (CEO) Meets Mauritius Minister of Gender Equality & Family Welfare to Launch "Educating Linda" Program, Supporting Education of 20 Deserving yet Underprivileged Mauritian Schoolgirls Girls Until Graduation
During the visit to the country, Merck Foundation CEO also met the Mauritius President to share the impact of their 100 Scholarships for Mauritian Doctors in partnership with Ministry of Health. Dr. Rasha Kelej during her meeting with the Mauritius President, strengthened partnership to improve access to innovative and equitable healthcare and Empower Women in STEM. Senator Dr. Rasha Kelej also met the Mauritius Minister of Gender Equality&Family Welfare to share the impact of their programs to address critical social issues like supporting girl education and Ending Gender Based Violence in the country. Senator, Dr. Rasha Kelej, CEO of Merck Foundation ( the philanthropic arm of Merck KGaA Germany met Hon'ble Ms. Marie Arianne Navarre-Marie, Minister of Gender Equality and Family Welfare during a high-level meeting, to share the impact of their programs and underscore their long-term commitment to address critical social issues in Mauritius. During her visit, she also met H.E. MR. DHARAMBEER GOKHOOL, The President of Republic of Mauritius, to share the impact of their 100 Scholarships for Mauritian Doctors in partnership with Ministry of Health and underscore their long-term commitment to transform public healthcare in Mauritius. Senator, Dr. Rasha Kelej, CEO of Merck Foundation and President of 'More Than a Mother' Campaign emphasized, 'It was a great honor to meet Hon'ble Ms. Marie Arianne Navarre-Marie, Minister of Gender Equality and Family Welfare and share with her the impact of our partnership and programs since 2017 that aim to transform patient care, build healthcare and media capacity, to empower women in STEM, support girl education and raise awareness about social and health issues in Mauritius and the rest of Africa. I am very happy to share that together with the Ministry of Gender Equality and Family Welfare, we are launching our Educating Linda Program in the country, as a part of which we will be supporting the education of 20 high performing yet underprivileged Mauritian schoolgirls, till they graduate. Through this, we will be empowering them to complete their studies and reach their full potential.' Merck Foundation has provided 100 scholarships for Mauritian doctors in 44 critical and under-served specialties. 'During my meeting with H.E. MR. DHARAMBEER GOKHOOL, The President of Republic of Mauritius, we also discussed the possibility of providing specialized training for Mauritian doctors in innovative and emerging fields such as Stem Cell Therapy in pathology, CAR T-cell treatment, AI in Radiology, Radiotherapy and Medical Oncology, Robotic Surgical Oncology, Neurology, Nephrology, Urology, and Neurosurgery. We are strongly committed to work closely with Ministry of Health to improve access to innovative and equitable healthcare solutions', added Dr. Kelej. The 100 scholarships for local Mauritian Doctors have been provided for One-Year PG Diploma and Two-year Master Degrees in many critical specialties including Fertility, Embryology, Sexual&Reproductive Care, Oncology, Preventative Cardiovascular, Diabetes, Endocrinology, Acute Medicine, Respiratory, Gastroenterology, Dermatology, Neuroimaging for Research, Sexual&Reproductive Care, Clinical Microbiology and infectious diseases, Internal Medicine, Pediatric Emergency Medicine, Ophthalmology, Laparoscopic Surgical Skills, Critical Care, Neonatal Medicine, Psychiatry, Family Medicine, Advanced Cytopathology and many more. Merck Foundation has so far provided more than 2280 scholarships for young doctors from 52 countries in 44 critical and underserved specialties, with many of them becoming the first specialists in their countries. During her visit, Merck Foundation CEO also met the Senior Officials from the Office of Hon'ble Minister of Health, Mauritius. Merck Foundation also conducted the 4 th Edition of their Health Media Training for the Mauritian Media Representatives in partnership with Ministry of Gender Equality and Family Welfare, Mauritius. The training session was conducted to emphasize on the important role that media plays to influence society to create a cultural shift with the aim to address wide range of social and health issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, Stopping GBV, Diabetes and Hypertension awareness. It was co-chaired by Merck Foundation CEO and Minister of Gender Equality and Family Welfare, Mauritius. During the training session, the Call for Application for 8 important Merck Foundation Awards were announced for Media, Musicians, Fashion Designers, Filmmakers, students, and new potential talents in these fields. The award announced are: Merck Foundation Africa Media Recognition Awards 'More Than a Mother' 2025, in partnership with Media Trust Board, Mauritius: Media representatives and media students are invited to showcase their work to raise awareness about one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels. Submission deadline: 30 th September 2025. Merck Foundation Fashion Awards 'More Than a Mother' 2025, in partnership with Academy of Design and Innovation, Mauritius: All African Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to raise awareness about one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels. Submission deadline: 30 th September 2025. Merck Foundation Film Awards 'More Than a Mother' 2025: All African Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to address one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels. Submission deadline: 30 th September 2025. Merck Foundation Song Awards 'More Than a Mother' 2025: All African Singers and Musical Artists are invited to create and share a SONG with the aim to address one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels. Submission deadline: 30 th September 2025. Merck Foundation Media Recognition Awards 2025 'Diabetes&Hypertension', in partnership with Media Trust Board, Mauritius: Media representatives are invited to showcase their work through strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Merck Foundation Fashion Awards 2025 'Diabetes&Hypertension', in partnership with Academy of Design and Innovation, Mauritius: All African Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Merck Foundation Film Awards 2025 'Diabetes&Hypertension: All African Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to promote a healthy lifestyle raise awareness about prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Merck Foundation Song Awards 2025 'Diabetes&Hypertension': All African Singers and Musical Artists are invited to create and share a SONG with the aim to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Entries for the above awards can be submitted to us at: submit@ For information on the above awards, please visit our website: Distributed by APO Group on behalf of Merck Foundation. Contact: Mehak Handa Community Awareness Program Manager Phone: +91 9310087613/ +91 9319606669 Email: Join the conversation on our social media platforms below and let your voice be heard! Facebook: X: YouTube: Instagram: Threads: Flickr: Website: Download Merck Foundation App: About Merck Foundation: The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality&equitable healthcare solutions in underserved communities, building healthcare&scientific research capacity, empowering girls in education and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit to read more. Follow the social media of Merck Foundation: Facebook ( X ( Instagram ( YouTube ( Threads ( and Flickr ( The Merck Foundation is dedicated to improving social and health outcomes for communities in need. While it collaborates with various partners, including governments to achieve its humanitarian goals, the foundation remains strictly neutral in political matters. It does not engage in or support any political activities, elections, or regimes, focusing solely on its mission to elevate humanity and enhance well-being while maintaining a strict non-political stance in all of its endeavors.
Zawya
17-07-2025
- Zawya
KFSHRC performs world's first robotic-assisted BiVAD Implantation
A minimally invasive robotic surgery offers a life-saving option for high-risk patients who cannot undergo transplants or traditional open-heart procedures King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world's first implantation of two artificial pumps for biventricular support (BiVAD-HMIII) using robotic technology on a patient with advanced heart failure. This groundbreaking procedure opens new horizons in circulatory support techniques for patients with complex cardiac conditions and marks a medical achievement that culminated in the patient's recovery within a short period following the surgery. The procedure represents a major advancement in the treatment of bilateral heart failure, which was traditionally performed through full sternotomy, an approach associated with higher surgical risks and prolonged recovery. However, the cardiac surgery team at KFSHRC, led by Prof. Feras Khaliel, successfully performed the operation through small incisions using remotely controlled high-precision robotic arms, resulting in reduced blood loss, lower risk of infection, and faster patient recovery. The 61-year-old patient was admitted after spending over two months bedridden, suffering from end-stage heart failure unresponsive to medical therapy, in addition to multiple chronic conditions including diabetes, stroke, and renal impairment. After a comprehensive clinical evaluation, the patient was deemed ineligible for a heart transplant, making robotic implantation of the artificial pumps a vital and unique solution suited to his health status. This milestone reflects the integration of expertise across multiple departments at KFSHRC including cardiac surgery, cardiology, anesthesia, critical care, biomedical engineering, and advanced life support. The procedure was meticulously planned and benefited from 3D imaging technologies, real-time surgical navigation, and innovative solutions for safely securing the mechanical assist devices. KFSHRC aims to publish the results of this procedure in peer-reviewed medical journals and present them at global cardiology conferences to promote knowledge exchange and establish innovative partnerships with leading international centers in robotic care and advanced heart failure management. This achievement adds to KFSHRC's track record in robotic surgery which includes the world's first fully robotic heart transplant and the World's First Robotic-Assisted Artificial Heart Pump Implantation. These milestones serve as evidence of its leadership in adopting cutting-edge cardiac technologies and managing critical conditions with the highest standards of precision and safety, further reinforcing its position as a leading academic medical center both regionally and globally. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Web Release
09-07-2025
- Web Release
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards. For more information, visit or contact our media team at [email protected]
